Physician profile
Sergio Lugo
NPI 1922285816
$402.84
in general payments reported to CMS, 2019-2025
10 companies · $22.31 in 2025
The $22.31 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.07 · 2020: $18.01 · 2021: $85.20 · 2022: $49.46 · 2023: $134 · 2024: $40.27 · 2025: $22.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $95.49 | 2023 | Valtoco |
| Amgen INC. | $88.01 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $74.34 | 2022-2023 | Andexxa |
| Smith+Nephew, INC. | $41.10 | 2019 | |
| Novocure INC. | $24.06 | 2024 | Optune |
| Eisai INC. | $22.31 | 2025 | |
| Argenx US, INC. | $16.21 | 2024 | Vyvgart Hytrulo |
| Biohaven Pharmaceuticals, INC. | $15.20 | 2021 | |
| Acadia Pharmaceuticals INC | $13.15 | 2022 | |
| Allergan, INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Lugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.